Elevating future therapies to a new level: Greenovation transformed into Eleva. Join us at www.elevabiologics.com


Greenovation is managed by Dr. Andreas Schaaf and Jörg Alexander Ronde, who have extensive scientific and business experience in biotechnology.

Andreas Schaaf, PhD, Head of R&D

Dr. Andreas Schaaf, Managing Director / CSO

Andreas Schaaf holds a PhD in plant biotechnology. Before joining Greenovation as research scientist in 2009, he held positions at the University of Muenster and Freiburg. At Greenovation, Andreas was responsible for advancing BryoTechnology to a fully viable biopharmaceutical platform. Andreas has been Chief Scientific Officer since 2015 and was appointed Managing Director at the end of 2019.

Jörg Alexander Ronde, Managing Director / CCO

Jörg Alexander Ronde studied economics at the University of Gießen. As managing director of several companies, he has many years of experience in business and strategy development. Jörg has been a consultant for Greenovation since 2018. Since August 2019 he has been managing director.